Journey Study

Schizophrenia is a complex disorder and is not well understood. 

Researchers believe that a combination of genetics and environment contributes to its development and problems with certain naturally occurring brain chemicals, may also be contributors. 

Current treatment options include different antipsychotic medications.

Research is underway on a study drug for individuals who still experience symptoms despite treatment. 

It is a 16-week study that will evaluate the effect of adjunctive Valbenazine vs placebo on symptoms of schizophrenia in subjects who have an inadequate response to antipsychotic treatment.

The purpose of this study is to evaluate if the study drug, may help with schizophrenia symptoms compared to placebo (a substance that looks like Valbenzine but does not contain active drug)

Your time and effort will be financially rewarded.

You can withdraw at any time, for any reason you want.